Maynard Um
-
-
-
-
-
-
-
BeOne Medicines (ONC) Reiterated at Market Outperform by Citizens After PRMT5i Presentation
-
-
-
-
-
-
-
BeOne Medicines (ONC) PT Raised to $410 at Guggenheim
-
-
-
-
-
-
-
BeOne Medicines reports positive results from cancer drug trial
-
-
-
-
-
-
-
BeOne Medicines (ONC) PT Raised to $405 at Citi
-
-
-
-
-
-
-
RBC Capital on Biotech Shares: 'Company-Specific Volatility For Quality Names May Be Overdone'
-
-
-
-
-
-
-
BeiGene, Ltd. (ONC) Misses Q2 EPS by 4c, provides guidance
-
-
-
-
-
-
-
RBC Capital Highlights BeOne Medicines' (ONC) Rich Pipeline
-
404,866 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

